GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc., formerly trading under the SPAC ticker CPSR as Capstar Special Purpose Acquisition Corp, completed its business combination in January 2022 via an 8-K filing dated January 10, 2022. The SPAC was sponsored by Capstar SPAC Sponsor LLC and conducted its initial public offering in 2021, targeting the healthcare and life sciences sector. Gelesis, the combined company, is a biotherapeutics firm focused on treating chronic diseases linked to the gastrointestinal pathway, including obesity and type 2 diabetes, through its superabsorbent hydrogel platform. The company subsequently listed on the NYSE under the ticker GLS following the merger close. Sign up on SpacDesk for full filing history, sponsor details, and deal analytics on Gelesis Holdings and hundreds of other SPAC transactions.